These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18275405)

  • 1. Health consumer and patients' organizations in Europe: towards a comparative analysis.
    Baggott R; Forster R
    Health Expect; 2008 Mar; 11(1):85-94. PubMed ID: 18275405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Representing Whom? U.K. Health Consumer and Patients' Organizations in the Policy Process.
    Baggott R; Jones KL
    J Bioeth Inq; 2018 Sep; 15(3):341-349. PubMed ID: 29802590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The voluntary sector and health policy: the role of national level health consumer and patients' organisations in the UK.
    Baggott R; Jones K
    Soc Sci Med; 2014 Dec; 123():202-9. PubMed ID: 25085720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Big Society in an age of austerity: threats and opportunities for Health Consumer and Patients' Organizations in England.
    Baggott R; Jones K
    Health Expect; 2015 Dec; 18(6):2164-73. PubMed ID: 24602084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention better than cure? Health consumer and patients' organisations and public health.
    Baggott R; Jones KL
    Soc Sci Med; 2011 Aug; 73(4):530-534. PubMed ID: 21802183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European priorities for research on health care organizations and service delivery.
    Hansen J; Schäfer W; Black N; Groenewegen P
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():16-26. PubMed ID: 21737526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing the National Knowledge Platform in India: a policy and institutional analysis.
    Sriram V; Bennett S; Raman VR; Sheikh K
    Health Res Policy Syst; 2018 Feb; 16(1):13. PubMed ID: 29463256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To prevent alcohol problems in Europe by community actions--various national and regional contexts.
    Larsson S; Hanson BS
    Subst Use Misuse; 2000 Jan; 35(1-2):11-30. PubMed ID: 10677873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material.
    Nilsen ES; Myrhaug HT; Johansen M; Oliver S; Oxman AD
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD004563. PubMed ID: 16856050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Realisation of a joint consumer engagement strategy in the Nepean Blue Mountains region.
    Blignault I; Aspinall D; Reay L; Hyman K
    Aust J Prim Health; 2017 Dec; 23(6):531-535. PubMed ID: 28196579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One For All, All For One? Collective Representation in Healthcare Policy.
    Jongsma K; Rimon-Zarfaty N; Raz A; Schicktanz S
    J Bioeth Inq; 2018 Sep; 15(3):337-340. PubMed ID: 30014364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power and Politics in the Global Health Landscape: Beliefs, Competition and Negotiation Among Global Advocacy Coalitions in the Policy-Making Process.
    McDougall L
    Int J Health Policy Manag; 2016 Jan; 5(5):309-20. PubMed ID: 27239880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Civil society organisations, social innovation and health research in Europe.
    Beinare D; McCarthy M
    Eur J Public Health; 2012 Dec; 22(6):889-93. PubMed ID: 22117053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening capacity to apply health research evidence in policy making: experience from four countries.
    Hawkes S; K Aulakh B; Jadeja N; Jimenez M; Buse K; Anwar I; Barge S; Odubanjo MO; Shukla A; Ghaffar A; Whitworth J
    Health Policy Plan; 2016 Mar; 31(2):161-70. PubMed ID: 25900967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sector cooperation in health-enhancing physical activity policymaking: more potential than achievements?
    Hämäläinen RM; Aro AR; Lau CJ; Rus D; Cori L; Syed AM;
    Health Res Policy Syst; 2016 Apr; 14(1):33. PubMed ID: 27129850
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.